ERYTECH Pharma completes the enrollment of patients in its Phase I clinical trial in pancreatic cancer

ERYTECH Pharma has just completed the enrollment of patients in a Phase I clinical trial with its flagship product for pancreatic cancer, Graspa®.

Menu